Global Demand for Brain Health Surges: JOYLOSI Launches Patented cGP-II Formula in North American Ma

　　​Global consumer demand for cognitive health continues to expand, with precision nutrition emerging as one of the fastest-growing segments in the global wellness industry. Premium dietary nutrition brand JOYLOSI recently unveiled its flagship cognitive support product, the JOYLOSI cGP-II Capsule, powered by exclusive patented technology, across the North American market. The launch marks the brand’s comprehensive expansion into North America’s high-end nutrition sector and accelerates the rollout of its long-term global strategy.

　　Amid accelerating work rhythms in the digital age and shifting global demographic trends, brain health and cognitive nutrition have become one of the fastest-growing categories in the North American dietary supplement market, according to public industry data. Consumer focus on scientific backing, regulatory credibility, and tangible efficacy has risen steadily year over year. As a result, premium nutrition products built on core patented technologies and aligned with strict regulatory standards have emerged as the primary growth engine of the market.

　　The JOYLOSI cGP-II Capsule debuting in North America is the brand’s cornerstone product, developed on the backbone of cutting-edge global brain science research. The nutritional value of its key active component — the endogenous molecule cGP (cyclo-glycyl-proline) — was first identified by the research team at the University of Auckland’s Centre for Brain Research during foundational studies of endogenous molecular pathways.

　　Through in-house technological translation and development, JOYLOSI has commercialized this scientific breakthrough into its proprietary cGP-II® patented complex technology. The formulation supports homeostasis of cerebral microcirculation and facilitates the natural clearance of neurometabolic waste, thereby alleviating common cognitive fatigue symptoms including brain fog and diminished attention span, while helping to sustain overall cognitive vitality.

　　Beyond its core active ingredient, the product features a dual-complex formulation design paired with a synergistic system of 5-hydroxytryptophan (5-HTP) and vitamin B6. By modulating neurotransmitter balance, it delivers targeted benefits tailored to the full daily cycle: it helps ease emotional stress and maintain focused clarity during daytime hours, while supporting natural deep sleep cycles and improving overall sleep quality at night. The formulation delivers multi-dimensional nutritional support spanning cognitive function, emotional balance, and sleep wellness.

　　As a foundational pillar of its North American market entry, JOYLOSI has established a full-chain compliance framework covering brand registration, manufacturing, and quality control, fully aligned with North American regulatory requirements.

　　On the brand qualification front, JOYLOSI has secured official registration with the United States Patent and Trademark Office (USPTO) under registration number 90374635, covering Class 5 dietary supplements and health food categories. All products in the brand’s portfolio have completed compliance filings in strict adherence to U.S. Food and Drug Administration (FDA) regulations for dietary supplements.

　　In manufacturing, all products are produced in North American pharmaceutical-grade facilities with top-tier Good Manufacturing Practices (GMP) certification. A unified global high-standard quality control system is enforced across the entire value chain — from raw material traceability and production processes to finished product testing — ensuring the purity, safety, and stability of every batch.

　　In terms of channel strategy, JOYLOSI cGP-II Capsules have made their initial brick-and-mortar debut at VTAMINS, a leading U.S. professional health retail chain, with placement in premium retail outlets across key North American metropolitan areas. The unified retail price across the North American market is $52.99.

　　Looking ahead, JOYLOSI will continue to deepen partnerships with the world’s top scientific research institutions, iterate on its core formulation technologies, and gradually expand into additional regional markets. This development model — defined by global scientific collaboration, localized compliant operations, and omni-channel distribution — not only brings cutting-edge precision nutrition solutions to consumers worldwide, but also provides a replicable roadmap for premium dietary nutrition brands pursuing global growth. In doing so, it continues to drive the global wellness industry toward a more scientific, standardized, and innovation-led future.